Highest Revenue
checkbookThese companies stand out for their exceptional revenue generation and represent the industry's top performers.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardRevenue | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VORVor Biopharma | $0.86 | -$0.03 | arrow_drop_down3.82% | $59.08M | 385.03K | 0.87 | _ | Neutralremove | - | -55.00% | AI Analysis | |||||
CVVCVD Equipment | $2.91 | -$0.29 | arrow_drop_down9.06% | $19.85M | 87.44K | 2.89 | _ | Sellkeyboard_arrow_down | - | -47.53% | AI Analysis | |||||
 DALDelta Air Lines | $64.07 | -$0.80 | arrow_drop_down1.23% | $41.34B | 9.83M | 64.28 | _ | Sellkeyboard_arrow_down | 0.93% | 81.81% | AI Analysis | |||||
APXI APXIAPx Acquisition Corp. I | $11.86 | $0.01 | arrow_drop_up0.12% | $117.63M | 1.50K | 11.85 | _ | Neutralremove | - | 7.47% | AI Analysis | |||||
AUSTAustin Gold | $1.63 | -$0.11 | arrow_drop_down6.17% | $22.29M | 482.58K | 1.63 | _ | Neutralremove | - | 146.96% | AI Analysis | |||||
PIRSPieris Pharmaceuticals | $15.65 | -$0.11 | arrow_drop_down0.72% | $20.94M | 6.36K | 15.99 | _ | Neutralremove | - | -21.75% | AI Analysis | |||||
 GPCGenuine Parts Co | $122.62 | -$1.31 | arrow_drop_down1.05% | $17.04B | 1.07M | 123.20 | _ | Neutralremove | 3.23% | -11.30% | AI Analysis | |||||
CTXRCitius Pharmaceuticals | $0.20 | -$0.13 | arrow_drop_down40.40% | $36.14M | 11.26M | 0.21 | _ | Neutralremove | - | -74.13% | AI Analysis | |||||
NBYNovaBay Pharmaceuticals | $0.71 | -$0.03 | arrow_drop_down5.08% | $3.48M | 93.61K | 0.71 | _ | Neutralremove | - | -93.82% | AI Analysis | |||||
MBIOMustang Bio | $0.22 | -$0.00 | arrow_drop_down3.13% | $8.50M | 904.78K | 0.22 | _ | Neutralremove | - | -85.31% | AI Analysis | |||||
SNOASonoma Pharmaceuticals | $2.56 | $0.03 | arrow_drop_up1.16% | $3.42M | 15.24K | 2.59 | _ | Neutralremove | - | -17.78% | AI Analysis | |||||
SNDXSyndax Pharmaceuticals | $15.83 | -$0.97 | arrow_drop_down5.77% | $1.35B | 5.04M | 16.47 | _ | Neutralremove | - | 7.68% | AI Analysis | |||||
FORRForrester Research | $16.09 | -$0.63 | arrow_drop_down3.76% | $305.64M | 95.08K | 16.12 | _ | Neutralremove | - | -34.59% | AI Analysis | |||||
JAKKJAKKS Pacific | $26.74 | -$1.28 | arrow_drop_down4.51% | $297.87M | 259.34K | 27.03 | _ | Neutralremove | - | -5.24% | AI Analysis | |||||
SRZN SRZNWSurrozen | $0.01 | $0.01 | 0.00% | $0.00 | 1.00K | 0.01 | _ | Neutralremove | - | - | AI Analysis | |||||
GOVXGeoVax Labs | $2.38 | -$0.18 | arrow_drop_down6.89% | $20.71M | 850.22K | 2.48 | _ | Neutralremove | - | -70.25% | AI Analysis | |||||
ORNOrion Group Holdings | $7.56 | -$0.20 | arrow_drop_down2.57% | $294.48M | 433.24K | 7.61 | _ | Neutralremove | - | 53.44% | AI Analysis | |||||
COCPCocrystal Pharma | $2.15 | -$0.04 | arrow_drop_down1.81% | $21.87M | 63.00K | 2.24 | _ | Sellkeyboard_arrow_down | - | 14.36% | AI Analysis | |||||
SNPXSynaptogenix | $2.42 | -$0.15 | arrow_drop_down5.74% | $3.25M | 22.49K | 2.47 | _ | Neutralremove | - | -57.77% | AI Analysis | |||||
STRRStar Equity Holdings | $3.16 | $0.06 | arrow_drop_up2.25% | $10.21M | 5.60K | 3.16 | _ | Buykeyboard_arrow_up | - | -26.70% | AI Analysis |
Showing 4461-4480 of 4977
Results per page:
About Highest Revenue
Enter the realm of stocks with the highest revenue, where companies are crushing their sales targets and achieving remarkable financial success. Revenue is a critical metric that measures a company's top-line performance, reflecting its ability to generate substantial income from its products or services.
Investors seeking promising opportunities often look to stocks with impressive revenue figures, as it indicates the company's market strength and demand for its offerings. These high revenue stocks can be attractive options for long-term investors seeking stable and prosperous ventures.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools